医学
肝细胞癌
转移
切除术
外科
肝切除术
外科切除术
全肺切除术
肺
内科学
癌症
作者
Yoshito Tomimaru,Yo Sasaki,Terumasa Yamada,Hidetoshi Eguchi,Koji Takami,Hiroaki Ohigashi,Masahiko Higashiyama,Osamu Ishikawa,Ken Kodama,Shingi Imaoka
标识
DOI:10.1016/j.amjsurg.2005.12.006
摘要
Background Pulmonary metastasis, which is the most common type of extrahepatic recurrence of hepatocellular carcinoma (HCC), has been considered unsuitable for surgical resection because most pulmonary metastases are multiple. Until now there have been few reports about surgical resection for pulmonary metastasis from HCC. The aim of the present study was to evaluate the significance of surgical resection for pulmonary metastasis from HCC. Methods Among 615 patients who underwent radical hepatic resection for HCC in our hospital over the past 15 years, 8 patients who had developed 1 or 2 pulmonary metastases underwent pulmonary resection for the pulmonary metastases (resection group), the other 6 patients who had developed 1 or 2 pulmonary metastases did not undergo pulmonary resection (nonresection group). The clinicopathologic features and long-term prognosis of the resection group were examined and compared with those of the nonresection group. Results In the resection group, although intrahepatic recurrences were present before the diagnosis of pulmonary metastasis in 4 patients, they were well controlled by repeated transarterial chemoembolization and/or further hepatic resections. The average survival periods after the pulmonary resection and after the initial hepatic resection were 29 months (range, 5–80 mo) and 61 months (range, 24–133 mo), respectively. No patients in the resection group showed pulmonary recurrence after the pulmonary resection, and the cause of death of the patients in the resection group was not pulmonary metastasis. The survival rate of patients in the resection group was significantly better than that in the nonresection group. Conclusions It may be concluded that surgical resection for pulmonary metastasis from HCC might be beneficial in selected patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI